UPDATE 1-AstraZeneca to buy Actavis lung drugs as Q4 earnings fall short By: Reuters: Company News February 05, 2015 at 03:20 AM EST * Q4 core EPS 76 cents vs consensus 82 cents (Adds further details on Actavis deal, more on outlook, shares) Read More >> Related Stocks: ALM Actavis Plc Astrazeneca Plc ADR Pfizer Teva Pharmaceutical Industries ADR